Upstream Bio (UPB) Return on Sales (2024 - 2025)
Historic Return on Sales for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 49.38%.
- Upstream Bio's Return on Sales fell 230400.0% to 49.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 43.64%, marking a year-over-year decrease of 177200.0%. This contributed to the annual value of 27.7% for FY2024, which is 125900.0% down from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Return on Sales is 49.38%, which was down 230400.0% from 42.6% recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Return on Sales registered a high of 12.66% during Q3 2023, and its lowest value of 49.38% during Q3 2025.
- Moreover, its 3-year median value for Return on Sales was 28.75% (2024), whereas its average is 32.5%.
- As far as peak fluctuations go, Upstream Bio's Return on Sales tumbled by -61800bps in 2024, and later plummeted by -267000bps in 2025.
- Upstream Bio's Return on Sales (Quarter) stood at 28.47% in 2023, then decreased by -22bps to 34.65% in 2024, then crashed by -43bps to 49.38% in 2025.
- Its Return on Sales was 49.38% in Q3 2025, compared to 42.6% in Q2 2025 and 48.18% in Q1 2025.